Amorfix names Gundel as VP of R&D
January 6, 2010 by leonardzehr · Leave a Comment
Amorfix Life Sciences (TSX:AMF) has appointed 25-year drug development veteran Dr. Robert Gundel as vice president of research and development. “Robert’s extensive record of new product advancement will be a great asset as we continue to discover, develop and commercialize novel diagnostic and therapeutic products based on our Epitope Protection and ProMIS technology platforms,” Dr. [...]
Listen to BioTuesdays 
